AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Eli Lilly's Optimism
Motley Fool Money
Will Insurers Pay for Obesity Therapies?
One of the big issues is will insurers pay for these treatments? There's been debate back and forth. Novo Nordisk, which has a rival weight loss drug, Wigovi found that their their medication helps reduce the incidence of heart attack strokes by 20% in obese and overweight people.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode